We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+11.62%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$102B
AUM Growth
+$4.89B
(+5%)
Cap. Flow
-$14.3B
Cap. Flow
% of AUM
-14.05%
Top 10 Holdings %
Top 10 Hldgs %
21.48%
Holding
2,932
New
37
Increased
642
Reduced
1,943
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$442M |
| 2 |
SLB Ltd
SLB
|
+$418M |
| 3 |
Verizon
VZ
|
+$404M |
| 4 |
Bank of America
BAC
|
+$370M |
| 5 |
Rockwell Automation
ROK
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
UnitedHealth
UNH
|
+$646M |
| 3 |
CrowdStrike
CRWD
|
+$621M |
| 4 |
Marvell Technology
MRVL
|
+$617M |
| 5 |
Apple
AAPL
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.33% |
| 2 | Consumer Discretionary | 10.38% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 8.56% |
| 5 | Industrials | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KALV
2451
DELISTED
KalVista Pharmaceuticals
KALV
| $122K | ﹤0.01% |
10,290
-2,249
| -18% | -$30K |
|
|
INZY
2452
DELISTED
Inozyme Pharma
INZY
| $122K | ﹤0.01% |
15,914
-4,166
| -21% | -$22.9K |
|
2453
Ranpak Holdings
PACK
$464M
| $121K | ﹤0.01% |
15,409
-4,589
| -23% | -$24.1K |
|
|
TAST
2454
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $121K | ﹤0.01% |
12,684
-3,103
| -20% | -$28.7K |
|
2455
Target Hospitality
TH
$1.61B
| $120K | ﹤0.01% |
11,014
-1,809
| -14% | -$17K |
|
2456
NextNav
NN
$2.62B
| $118K | ﹤0.01% |
17,997
-5,311
| -23% | -$23.7K |
|
2457
Custom Truck One Source
CTOS
$2.46B
| $118K | ﹤0.01% |
20,316
-5,894
| -22% | -$36.6K |
|
2458
SkinHealth Systems
SKIN
$84.2M
| $118K | ﹤0.01% |
26,610
-7,110
| -21% | -$23.1K |
|
|
ENFN
2459
DELISTED
Enfusion, Inc.
ENFN
| $118K | ﹤0.01% |
12,745
-2,802
| -18% | -$24.7K |
|
2460
Vivid Seats
SEAT
$81.6M
| $117K | ﹤0.01% |
978
+474
| +94% | +$55.6K |
|
2461
Phathom Pharmaceuticals
PHAT
$742M
| $117K | ﹤0.01% |
11,019
-1,824
| -14% | -$15.5K |
|
2462
Tango Therapeutics
TNGX
$4.31B
| $117K | ﹤0.01% |
14,728
-3,721
| -20% | -$39.9K |
|
2463
Consumer Portfolio Services
CPSS
$205M
| $116K | ﹤0.01% |
15,354
| – | – |
|
2464
Arbutus Biopharma
ABUS
$907M
| $116K | ﹤0.01% |
44,905
-11,388
| -20% | -$29.5K |
|
2465
Atea Pharmaceuticals
AVIR
$405M
| $115K | ﹤0.01% |
28,547
-4,739
| -14% | -$18.5K |
|
2466
Viemed Healthcare
VMD
$353M
| $115K | ﹤0.01% |
12,157
-3,177
| -21% | -$27.2K |
|
2467
Microvision
MVIS
$111M
| $114K | ﹤0.01% |
4,142
-886
| -18% | -$30.1K |
|
2468
Sutro Biopharma
STRO
$353M
| $113K | ﹤0.01% |
2,006
-596
| -23% | -$26.3K |
|
|
CMBM
2469
DELISTED
Cambium Networks
CMBM
| $113K | ﹤0.01% |
+26,279
| New | +$118K |
|
2470
Pulmonx
LUNG
$98.4M
| $113K | ﹤0.01% |
12,159
-2,977
| -20% | -$34.9K |
|
|
DSKE
2471
DELISTED
Daseke, Inc. Common Stock
DSKE
| $112K | ﹤0.01% |
13,447
-3,382
| -20% | -$27.7K |
|
|
CNSL
2472
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $111K | ﹤0.01% |
25,806
-4,258
| -14% | -$18.5K |
|
2473
Solid Power
SLDP
$536M
| $111K | ﹤0.01% |
54,610
-9,348
| -15% | -$14.2K |
|
2474
AMC Entertainment Holdings
AMC
$2.26B
| $110K | ﹤0.01% |
29,566
+4,731
| +19% | +$21.1K |
|
2475
iQIYI
IQ
$1.28B
| $110K | ﹤0.01% |
25,901
-4,208
| -14% | -$16.2K |
|
Similar funds
VAM
VOYA Investment Management's Q1 2024 Portfolio in Review
As of Q1 2024, VOYA Investment Management held 2,932 positions worth $102B, up 5% from $97.1B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
VOYA Investment Management withdrew a net $14.3B in Q1 2024, closing 149 positions and reducing 1,943 holdings. Its most notable exit was Cameco, an estimated $69.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, VOYA Investment Management opened a new position in T. Rowe Price Capital Appreciation Equity ETF worth $86.5M.
- VOYA Investment Management's largest Q1 2024 buy was T. Rowe Price Capital Appreciation Equity ETF: 2,861,296 shares worth $86.5M.
- VOYA Investment Management added most to GE Aerospace in Q1 2024, an estimated $442M increase.
- VOYA Investment Management's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.29B.
- VOYA Investment Management fully exited Cameco in Q1 2024, selling an estimated $69.1M.
- VOYA Investment Management's ten largest holdings make up 21% of its $102B portfolio in Q1 2024.
- VOYA Investment Management opened 37 new positions and closed 149 in Q1 2024.
- VOYA Investment Management's portfolio value rose 5% quarter-over-quarter to $102B.
Based on VOYA Investment Management's 13F filing for Q1 2024, filed 15 May 2024.